late-breaking abstract: eltrombopag improves response in severe aplastic anemia
Published 8 years ago • 2.7K plays • Length 6:31Download video MP4
Download video MP3
Similar videos
-
5:14
eltrombopag increases hematologic response in patients with treatment-naïve severe aplastic anemia
-
2:55
race: evaluating eltrombopag in severe aplastic anemia
-
4:25
frontline shift for severe aplastic anemia after eltrombopag fda approval
-
1:41
dr. deol on the fda approval of eltrombopag in severe aplastic anemia
-
5:27
conversations with innovators: neal young, md
-
4:33
the role of supportive care in severe aplastic anemia
-
5:35
exciting new immunosuppressive therapy treatment for aplastic anaemia
-
3:45
a two-year analysis of the ebmt-saawp race trial: eltrombopag in aplastic anemia
-
15:23
non-transplant treatments for aplastic anemia
-
11:21
ash 2016: aplastic anemia research update
-
3:00
advances in transplantation and drug treatments for idiopathic aplastic anemia
-
59:00
updates from ash 2019 the latest in aplastic anemia and pnh
-
2:01
eltrombopag for aplastic anaemia in europe
-
0:50
dr. young on eltrombopag added to immunosuppression for patients with aplastic anemia
-
8:10
unmet needs in severe aplastic anemia and exciting ongoing developments
-
1:19
upcoming saa research: cyclosporine and eltrombopag
-
1:43
unmet needs in aplastic anemia: dealing with severe infections & managing elderly patients
-
1:52
eltrombopag for cmml patients with thrombocytopenia
-
59:42
learning about aplastic anemia